Helus Pharma Inc.(HELP)

Medical - Pharmaceuticals · Toronto, ON

$10.65-0.77 (-6.74%)

Delayed quote: Oct 6, 2026, 3:30 PM EDT

Helus Pharma (HELP) EV/EBIT: History & Chart | TGMCharts

EV/EBIT Ratio: N/A

Basis: Current FMP quote-based enterprise value / four-quarter operating income. Source: stored company filings and market data; unavailable inputs remain N/A.

The EV/EBIT ratio is N/A as of 2026-10-06T19:36:55.792Z.

Stored calculation inputs

Calculation as of: 2026-10-06T19:36:55.792Z.

Quote observation: 2026-10-06T19:35:13.000Z. Amounts in USD. The price header may show a later quote.

Quote market capitalization: 659,510,845
Total debt · period ending 2026-06-30: 0
Cash · period ending 2026-06-30: 166,165,362
TTM operating income · period ending 2026-06-30: -177,170,375

FMP input reference: 934548bd97ab8c390298f716fcf622fc2d1107cfab085c47b2b47650fd31fbc6

EV/EBITDA|EV/Sales|Operating Income|All Metrics

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

HELP EV/EBIT Ratio Metrics

EV/EBIT RATIO

N/A

HELP Competitors' EV/EBIT Ratio

HELP

Helus Pharma Inc.

Current

Market Cap

$659.51M

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

FDMT

4D Molecular Therapeutics, Inc.

vs HELP

Market Cap

$660.25M

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

STLN

Starling Oncology, Inc.

vs HELP

Market Cap

$658.39M

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ANNX

Annexon, Inc.

vs HELP

Market Cap

$665.12M

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

MDXG

MiMedx Group, Inc.

vs HELP

Market Cap

$660.28M

EV/EBIT Ratio

60.10x

TTM Avg

21.67x

3Y Avg

25.85x

5Y Avg

35.25x

AVBP

ArriVent BioPharma, Inc.

vs HELP

Market Cap

$676.27M

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

PRME

Prime Medicine, Inc.

vs HELP

Market Cap

$640.29M

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

SLDB

Solid Biosciences Inc.

vs HELP

Market Cap

$680.56M

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

VSTM

Verastem, Inc.

vs HELP

Market Cap

$685.38M

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

AURA

Aura Biosciences, Inc.

vs HELP

Market Cap

$631.48M

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	EV/EBIT RATIO	TTM	3Y	5Y
Helus Pharma Inc. (HELP)	$659.51M	N/A	N/A	N/A	N/A
4D Molecular Therapeutics, Inc. (FDMT)vs ›	$660.25M	N/A	N/A	N/A	N/A
Starling Oncology, Inc. (STLN)vs ›	$658.39M	N/A	N/A	N/A	N/A
Annexon, Inc. (ANNX)vs ›	$665.12M	N/A	N/A	N/A	N/A
MiMedx Group, Inc. (MDXG)vs ›	$660.28M	60.10x	21.67x	25.85x	35.25x
ArriVent BioPharma, Inc. (AVBP)vs ›	$676.27M	N/A	N/A	N/A	N/A
Prime Medicine, Inc. (PRME)vs ›	$640.29M	N/A	N/A	N/A	N/A
Solid Biosciences Inc. (SLDB)vs ›	$680.56M	N/A	N/A	N/A	N/A
Verastem, Inc. (VSTM)vs ›	$685.38M	N/A	N/A	N/A	N/A
Aura Biosciences, Inc. (AURA)vs ›	$631.48M	N/A	N/A	N/A	N/A

EV/EBIT Ratio Formula & Definition

EV/EBIT = Enterprise Value / EBIT (TTM)

Enterprise value to EBIT compares total company value to operating earnings, accounting for depreciation unlike EV/EBITDA.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

EV/EBIT Ratio: N/A

HELP EV/EBIT Ratio Metrics

HELP Competitors' EV/EBIT Ratio

EV/EBIT Ratio Formula & Definition

Related Metrics